PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

157 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
121.
Menni, C.* et al.: Biomarkers for type 2 diabetes and impaired fasting glucose using a non-targeted metabolomics approach. Diabetes 62, 4270-4276 (2013)
122.
Monti, P.* ; Brigatti, C.* ; Krasmann, M. ; Ziegler, A.-G. & Bonifacio, E.*: Concentration and activity of the soluble form of the interleukin-7 receptor α in type I diabetes identifies an interplay between hyperglycemia and immune function. Diabetes 62, 2500-2508 (2013)
123.
Ott, V.* et al.: Oxytocin reduces reward-driven food intake in humans. Diabetes 62, 3418-3425 (2013)
124.
Renner, S.* et al.: Permanent neonatal diabetes in INSC94Y transgenic pigs. Diabetes 62, 1505-1511 (2013)
125.
Saxena, R.* et al.: Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. Diabetes 62, 1746-1755 (2013)
126.
Tabassum, R.* et al.: Genome-wide association study for type 2 diabetes in Indians identifies a new susceptibility locus at 2q21. Diabetes 62, 977-986 (2013)
127.
Wagner, R. et al.: Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans. Diabetes 62, 2106-2111 (2013)
128.
Xie, W.* et al.: Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes 62, 2141-2150 (2013)
129.
Billings, L.K.* et al.: Impact of common variation in bone-related genes on type 2 diabetes and related traits. Diabetes 61, 2176-2186 (2012)
130.
Marquez, M.* et al.: Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 61, 524-530 (2012)
131.
Renner, S.* et al.: Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass. Diabetes 61, 2166-2175 (2012)
132.
Tschöp, M.H. & DiMarchi, R.D.*: Outstanding scientific achievement award lecture 2011: Defeating diabesity: The case for personalized combinatorial therapies. Diabetes 61, 1309-1314 (2012)
133.
Yi, C.-X. et al.: Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity. Diabetes 61, 339-345 (2012)
134.
Ziegler, A.-G. et al.: Long-term protective effect of lactation on the development of type 2 diabetes in women with recent gestational diabetes mellitus. Diabetes 61, 3167-3171 (2012)
135.
Bonifacio, E. ; Warncke, K. ; Winkler, C. ; Wallner, M.* & Ziegler, A.-G.: Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk. Diabetes 60, 3300-3306 (2011)
136.
Hivert, M.F.* et al.: Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60, 1340-1348 (2011)
137.
Kanoni, S.* et al.: Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: A 14-cohort meta-analysis. Diabetes 60, 2407-2416 (2011)
138.
Pflueger, M. et al.: Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes 60, 2740-2747 (2011)
139.
Renström, F.* et al.: Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study. Diabetes 60, 345-354 (2011)
140.
Strawbridge, R.J.* et al.: Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60, 2624-2634 (2011)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... ▶▶ ▶▮